- Home
- TVTX vs CLSK Comparison
TVTX vs CLSK Comparison
Compare TVTX & CLSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TVTX | CLSK |
|---|---|---|
| Founded | N/A | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.4B |
| IPO Year | 2013 | 2008 |
Fundamental Metrics
Financial Performance| Metric | TVTX | CLSK |
|---|---|---|
| Price | $42.73 | $11.27 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 12 |
| Target Price | ★ $35.10 | $19.44 |
| AVG Volume (30 Days) | 1.4M | ★ 17.4M |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 92.89 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $766,314,000.00 |
| Revenue This Year | $43.88 | N/A |
| Revenue Next Year | $33.16 | $19.89 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 102.21 |
| 52 Week Low | $13.88 | $7.03 |
| 52 Week High | $42.13 | $23.61 |
Technical Indicators
Market Signals| Indicator | TVTX | CLSK |
|---|---|---|
| Relative Strength Index (RSI) | 77.59 | 63.98 |
| Support Level | $32.62 | $8.78 |
| Resistance Level | N/A | $14.04 |
| Average True Range (ATR) | 1.98 | 0.70 |
| MACD | 0.99 | 0.27 |
| Stochastic Oscillator | 100.00 | 84.11 |
Price Performance
Historical ComparisonAbout TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.
About CLSK CleanSpark Inc.
Cleanspark Inc. is a data center developer that, until recently, focused exclusively on bitcoin mining. The company provides scalable, energy-efficient digital infrastructure across the United States. The Company has a sole reporting segment, which is the bitcoin mining segment.